Study of the Surgical Treatment of Early Onset Scoliosis Using a Non-invasive Growing Rod
NCT ID: NCT01362881
Last Updated: 2017-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2012-01-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Magec is a magnetic growth rod from Ellipse technologies (distributed by SurgiC). The rod is inserted in exactly the same way as the conventional growth rod systems. The base implants i.e screws and hooks remain the preferred choice of the user. The only change is that a different rod is used.
There are several advantages to this device. Firstly, after the initial insertion, further lengthenings, unlike current systems, do not need to be carried out in theatre under a general anaesthetic. In contrast, they can be done in an outpatients setting with a non-invasive technique. The rods are lengthened using an external magnetic device. The lengthenings are done in a controlled manner using an age related growth guide. Thirdly, the change from a theatre based intervention to an outpatient procedure will have cost-savings. The investigators also believe that there will be psychosocial benefits to the child and family by the avoiding the stress associated with repeated surgery at such a young age.
In terms of risk assessment the device does not place the child at any more risk than would be expected from inserting any of the existing systems. In the event of failure of the rods the worst outcome is a revision to conventional rods.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Adolescent Idiopathic Scoliosis Patients Using the Ellipse MAGEC System
NCT01633931
Evaluation of a Modern System to Allow for Growth in Children With Scoliosis Versus a Conventional Treatment
NCT01672749
Surgical Treatment of Progressive Scoliosis With "NEMOST" Growing Rod
NCT02266667
Hospital-Based Cluster Trial: Magnetically Controlled Growing Rods Using Distraction Intervals
NCT04058561
The Treatment of Progressive Early Onset Spinal Deformities: A Multi-Center Outcome Study
NCT02299362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient who surgeon feels would benefit from the implantation of a growth rod
3. Patient must be of appropriate size and age for use of the device
4. Patient's guardian is willing and able to give informed consent for participation in the study
5. Patient (and guardian) is willing and able to return for all follow-up visits and study related procedures
6. The patient's guardian is willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study
Exclusion Criteria
1. Conversion patients with prior construct problems
2. Previous diagnosis of post-operative spinal infection or wound complication
3. Conversion patients with more than 3 previous distractions, or more than 2 years since initial surgery
4. Patients with prior failure of other devices
5. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study
6. Participants who have participated in another research study involving an investigational product in the past 12 weeks
2 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ellipse Technologies, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Colin Nnadi
Role: PRINCIPAL_INVESTIGATOR
Consultant Surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leeds Teaching Hospitals
Leeds, , United Kingdom
Oxford University NHS Trust
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Oxford Spine Unit
Oxford University R\&D
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SC-11-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.